OOIR: Observatory of International Research

Papers

(The TQCC of American Heart Journal is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	161
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	160
Table of Contents	92
Table of Contents	82
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	72
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease	68
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	64
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	51
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF	50
Editorial Board	48
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial	47
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes	40
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network	39
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network	39
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	36
Information for Readers	36
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	35
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	34
Information for Readers	34
The trial to assess chelation therapy 2 (TACT2): Rationale and design	34
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	33
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study	33
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections	33
Physician responses to apple watch-detected irregular rhythm alerts	32
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	32

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	29
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	28
Cardiac auscultation skills among medical trainees	28
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	28
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	27
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging	27
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	26
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	26
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	25
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	25
Cardiovascular Outcomes in Type 2 Diabetes Patients with Inflammatory Polyarthropathy: SGLT2 Inhibitors versus GLP-1 Receptor Agonists	24
Ambulatory inotropic therapy: To what end?	24
Editorial Board	24
Democracy, healthcare, and the public good	24
Information for Readers	24
Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction	23
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	23
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	23
Table of Contents	23
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	23
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	22
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	22
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	22
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	22
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	21
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	21
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	21
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	21
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	21
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	20
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	20
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial	20
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	19
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	19
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	19
Relationship between left atrial stiffness, pulmonary congestion, and impaired aerobic capacity in adults with repaired coarctation of aorta	19
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	19
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	19
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	18
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	18
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	18
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	18
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	18
Corrigendum to ``Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am He	18
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial	18
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in is	18
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	18
Editorial Board	18
GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: Cardiovascular Outcomes and Mortality Benefits	17
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	17

Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	17
Editorial Board	17
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	17
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	17
ISCHEMIA-EXTEND studies: Rationale and design	17
Neonatal outcomes of pregnancy in women with congenital heart disease	16
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	16
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	16
The effects of low-dose colchicine on the progression of aortic valve stenosis: Rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial	16
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial	16
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	16
Information for Readers	16
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	15
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	15
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	15
Prediabetes in Takotsubo Syndrome: Impact on Cardiovascular Outcomes and Mortality in a Propensity-Matched Cohort Study	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	15
Editorial Board	15
Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study	15
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	15
Information for Readers	15
Tricuspid valve disease prevalence and the impact of tricuspid valve surgery on cardiovascular events and hospital resource use in medicare beneficiaries	15
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study	15
Perioperative bleeding and outcomes after noncardiac surgery	15
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	15
Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is ‘paroxysmal’ atrial fibrillation?	14
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	14
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	14
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	14
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	14
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	14
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	14
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	14
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	14
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	14
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective	13
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	13
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	13
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	13
Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective	13
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	13
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	13
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	13
Association of change in QRS duration with chronic heart failure outcomes	13
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	13
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	12
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	12
Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers a	12
Editorial Board	12
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	12
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy	12
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	12
Table of Contents	12
Dysglycemia and incident heart failure among blacks: The jackson heart study	12
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure	12
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial	12
Rationale and design of European microcirculatory resistance and absolute flow team: The Euro-CRAFT registry	12
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	12
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	12
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROT	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Editorial Board	12
Editorial Board	12
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	11
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	11
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	11
Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes	11
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	11
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	11
Cardiovascular Risk in Obstructive Sleep Apnea: Impact of Glycemic Control in Diabetes — Insights from the TriNetX Network	11
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	11
Trends in urine drug screening and positivity among patients with heart failure: Insights from a large health system	11
Table of Contents	11
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	11

Precision Profiling of Advanced CVD and CKM Syndrome Through Lipidomics and Immunophenotyping	11
Information for Readers	11
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	11
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	11
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	11
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	11
Proportion of Obesity-Related Conditions Attributable to Obesity in US Adolescents and Young Adults	11
Editorial Board	11
Enhancing cardiac rehabilitation adherence through home-based rehabilitation and behavioral nudges: The ERA nudge study design and rationale	10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	10
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	10
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial	10
Editorial Board	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	10
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	10
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	10
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	10
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	10
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	10
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	10
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	10
Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions	10
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	10
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	10
OCEAN trial update	10
Table of Contents	10
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	9
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	9
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	9
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	9
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	9
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	9
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design	9
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	9
Editorial Board	9
Adiponectin as a Biomarker for Subclinical Atherosclerosis in Obese Adults with Type 2 Diabetes Mellitus	9
Prognosis of Hospitalizations of Patients with Different Phenotypes of Heart Failure in Type 2 Diabetes Mellitus	9
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	9
Table of Contents	9
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	9
Editorial Board	9
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	9
Editorial Board	9
Table of Contents	9
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	9
Prevalence and clinical correlates and characteristics of “Super Fontan”	9
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	9
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	9
Design and Rationale of the HD PCI Trial: A Cluster Randomized Crossover Trial of Higher vs. Lower Dose Heparin for Elective Percutaneous Coronary Intervention	9
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	9
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	9
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	9
Association Between Glycemic Control and Adverse Outcomes in Atrial Fibrillation: Evidence from a Large Real-World Cohort	9
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	8
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	8
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery	8
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	8
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
Information for Readers	8
Comparative Cardiovascular Outcomes Between Carvedilol and Metoprolol in Patients with Takotsubo Syndrome: A Propensity-Matched Cohort Study	8
Caribbean and South American Team-based Strategy to Control Hypertension (CATCH): Rationale and study design of a cluster randomized trial	8
Could paramedics use the HEART Pathway to identify patients at low-risk of myocardial infarction in the prehospital setting?	8
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	8
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation	8
The randomized controlled trial to compare temporary permanent pacemaker vs temporary pacemaker in patients with conduction block after transcatheter aortic valve replacement: Rationale and design of	8
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	8
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Incremental cost of complications after TAVR and SAVR in contemporary clinical practice	8
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	8
The pathophysiology of patent foramen ovale and its related complications	8
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study	8
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	8
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	8
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	8
A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial	7
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design	7
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)	7
Enrollment strategies in the era of digital revolution: Experience from a remote health management program	7
Hemodialysis and its impact on patient characteristics, microbiology, cardiac surgery, and mortality in infective endocarditis	7
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	7
Emergency department visits and hospitalizations after a diagnosis of angina with no obstructive coronary artery disease (ANOCA)	7
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease–2	7
Baseline NT-proBNP nonresponse score and health status measures in assessing treatment responses in heart failure with reduced ejection fraction	7
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry	7
at onal anish endocarditis st die – Design and objectives of the NIDUS registry	7
Hospital-level variation in cardiac rehabilitation metrics	7
Burden of cardiometabolic risk factors and vascular health	7
Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry	7